PERFLINK - PERFUSION LINKS

Add Link | New | What's Hot | Referrers | Personalize | Get Hits | Site Map

Tips

Current Directory

Link Navigation:

Home :: Myocardial Protection  

Showing page 1 of 1

Sort Order

 
Differential Depression of Myocardial Function  HOT

 2219 Hits Since 12/10/2004

[Vote] Votes: [14] Posts: [0] Threads: [0]

We conclude that for similar acute contractility depression, high [lactate] induces irreversible damage, likely at some point in the pathway of O2 utilization. In contrast, the effect of high [H+] appears reversible. These differential behaviors may have implications for heart function during heavy exercise and ischemia-reperfusion events.

Report Error | Send this page | Write Comment

Atlas of Myocardial Protection  HOT

 4168 Hits Since 12/10/2004

[Vote] Votes: [14] Posts: [0] Threads: [0]

This atlas, as part of the BrighamRAD project, is under development by the Decision Systems Group and the Division of Nuclear Medicine at the Department of Radiology, Brigham & Women's Hospital.

Report Error | Send this page | Write Comment

Myocardial Protection and Cardiopulmonary Bypass  HOT

 4262 Hits Since 12/10/2004

[Vote] Votes: [14] Posts: [0] Threads: [0]

Report Error | Send this page | Write Comment

Advances in Myocardial Protection  HOT

 5630 Hits Since 12/10/2004

[Vote] Votes: [14] Posts: [0] Threads: [0]

In 1975, anesthesiologists at the Cardiovascular Institute and Fu Wai Hospital began myocardial protection by perfusing cold crystalloid cardioplegic solutions into the ascending aorta. Since then, both clinical and basic research has been directed toward optimal myocardial protection. Current efforts have focused on the components of the arresting solution, the cardioplegic perfusate temperature, and perfusate methods.

Report Error | Send this page | Write Comment

Advances in Myocardial Protection   HOT

 1853 Hits Since 9/22/2004

[Vote] Votes: [14] Posts: [0] Threads: [0]

In 1975, anesthesiologists at the Cardiovascular Institute and Fu Wai Hospital began myocardial protection by perfusing cold crystalloid cardioplegic solutions into the ascending aorta. Since then, both clinical and basic research has been directed toward optimal myocardial protection. Current efforts have focused on the components of the arresting solution, the cardioplegic perfusate temperature, and perfusate methods.

Report Error | Send this page | Write Comment